Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on July 18, 2025
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
July 18, 2025
SAN CARLOS, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL …
Ascorbic Acid Market Size to Generate $2.2 Billion by 2031, Growing at a CAGR of 5.2%
EIN Presswire
·
July 18, 2025
Growing demand for functional food …
BIOPHARMA PEG Achieves FDA DMF Listings for Two PEG Derivatives
EIN Presswire
·
July 18, 2025
Two PEG-based intermediates from BIOPHARMA PEG now listed in FDA DMF, supporting regulatory needs for drug delivery and bioconjugation. WATERTOWN, MA, UNITED STATES, July 18, 2025 /EINPresswire.com/ -- BIOPHARMA PEG, a developer of functional …
US Wearable Technology market to grow at a CAGR of 15.4%: Wissen Research
GlobeNewswire
·
July 18, 2025
Sheridan, July 18, 2025 (GLOBE NEWSWIRE) -- According to the latest global wearable market report published by Wissen Research, the US wearable technology market was valued at USD 24 billion in 2024 and is expected to grow at a CAGR of 15.4% during the …
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 18, 2025
NOVATO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of …
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
GlobeNewswire
·
July 18, 2025
NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, …
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 18, 2025
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, effective as of July 17, 2025, the Compensation Committee of the …
Optimum Wound Care Center Details Multidisciplinary Approach to Healing Chronic and Complex Wounds in Louisville
EIN Presswire
·
July 18, 2025
Louisville clinic unveils care model blending diagnostics, advanced therapies, and education to boost healing of diabetic ulcers and pressure injuries. LOUISVILLE, KY, UNITED STATES, July 18, 2025 /EINPresswire.com/ -- Chronic wounds can be difficult to …
6th TimePie Longevity Forum: A Global Gateway to China’s 1.4 Billion Anti-Aging Opportunities
EIN Presswire
·
July 18, 2025
From science to solution, from policy to practice. SINGAPORE, July 18, 2025 /EINPresswire.com/ -- As China’s population ages rapidly, the development of the longevity industry has been prioritized to the level of national strategy since 2024. To …
Human Appeal USA Mobilizes Relief and Volunteer Event for Texas Flood Victims
GlobeNewswire
·
July 18, 2025
DALLAS, July 18, 2025 (GLOBE NEWSWIRE) -- In the wake of devastating floods across Texas, including persistent overflow from the Guadalupe River, Dallas-based nonprofit Human Appeal USA is taking action to support affected families with both on-the-ground …
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
GlobeNewswire
·
July 18, 2025
Company announcement – No. 17 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, July 18, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the …
Caregiver’s Compass – A New Book Helping Caregivers Get Through Dementia with Confidence
EIN Presswire
·
July 18, 2025
Caregiver’s Compass, by Alex J. Buison, offers real-life stories, expert advice, and practical tools for caregivers supporting loved ones with dementia. LAS VEGAS, NV, UNITED STATES, July 17, 2025 /EINPresswire.com/ -- Caring for a loved one with …
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GlobeNewswire
·
July 18, 2025
STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck, announced today that the European Commission (EC) granted conditional marketing authorization for EZMEKLY® (mirdametinib) for the treatment of …
Muscle Gain & Strength Supplements: How CrazyBulk Muscle Building Supplements Boost Strength and Maximize Muscle Performance Fast
GlobeNewswire
·
July 18, 2025
New York City, NY, July 18, 2025 (GLOBE NEWSWIRE) -- In the ever-evolving world of muscle building, performance, and strength enhancement, CrazyBulk has emerged as the name reshaping the conversation around legal supplements. As fitness communities move …
EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
GlobeNewswire
·
July 18, 2025
EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions ALK-Abelló A/S, which owns the rights to market EURneffy in the U.K., expects availability in late …
Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire
·
July 18, 2025
SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory …
Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors
GlobeNewswire
·
July 18, 2025
SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Generation Bio Announces 1-for-10 Reverse Stock Split
GlobeNewswire
·
July 18, 2025
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that it will implement a 1-for-10 …
Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
GlobeNewswire
·
July 18, 2025
SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics for the treatment of metabolic diseases, today announced …
Zevra Therapeutics Announces MIPLYFFA® and OLPRUVA® Presentations at the Annual Meeting of the Southeastern Regional Genetics Group (SERGG)
GlobeNewswire
·
July 18, 2025
CELEBRATION, Fla., July 18, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, announced that three posters on MIPLYFFA® …